Benzinga’s Top Pre-Market Gainers (MIPI, BPOP, CROX, ZIXI)

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) rose 176.67% to $4.15 in the pre-market session. Molecular Insight Pharmaceuticals, Inc. announced that results from a completed Phase 2 clinical trial of Onalta (Yttrium-90 edotreotide) have been published in the Journal of Clinical Oncology (JCO). The 52-week trading range for MIPI is $1.05 - $7.90. In the last six months, MIPI has declined over 71%.

Popular, Inc. (NASDAQ: BPOP) climbed 9.84% to $3.37 in the pre-market session. Popular, Inc. announced that it has commenced a public offering of depositary shares, each representing an interest in a share of Contingent Convertible Perpetual Non-Cumulative Preferred Stock, Series D, which is intended to raise $900 million. In the previous trading session, BPOP closed at $3.05. BPOP has declined over 5% in the last year.

Crocs, Inc. (NASDAQ: CROX) jumped 6.75% to $9.49 in the pre-market session. The 52-week trading range for CROX is $1.59 - $9.00. CROX closed at $9.49 in the last trading session. In the last six months, Crocs has gained over 25%.

Zix Corporation (NASDAQ: ZIXI) moved up 114.40% to $5.36 in the pre-market session. The 52 week trading range for ZIXI is $1.11 - $2.66. Zix Corporation closed at $2.50 in the previous trading session. ZIXI has gained over 17% in the last six months.